OA 1/2010/000038 A 20131025 20060101
A
61 K 39 09 A 20060101
C
07 K 14 315 A 20060101
C
07 K 19 00 A OA 1/2010/000038 20080801 GB 0714963.6 20070801 US 60/966,866 20070829 NOVARTIS AG
Lichtstrasse 35 CH
CH BAGNOLI, Fabio
Novartis Vaccines, Via Fiorentina 1 IT
BAROCCHI, Michèle
Novartis Vaccines, Via Fiorentina 1 IT
DONATI, Claudio
Novartis Vaccines, Via Fiorentina 1 IT
MASIGNANI, Vega
Novartis Vaccines, Via Fiorentina 1 IT
MUZZI, Alessandro
Novartis Vaccines, Via Fiorentina 1 IT
RUGGIERO, Paolo
Novartis Vaccines, Via Fiorentina 1 IT
SCP NICO HALLE & Co. LAW FIRM
ADRESSE A COMPLETER CM
Compositions comprising pneumococcal antigens. 20121231 015776 20280801 IB PCT/IB08/002866 20080801 IB WO/09/016515 20090205 20080801 20100201 20121231 20131025 BR Brevet PCT

The inventors believe that an effective Streptococcus pneumoniae vaccine may require several antigenic components, and so they have identified various combinations of pneumococcal polypeptides for use in immunisation. They have also identified some pneumococcal polypeptides that may be useful as single antigens. These polypeptides may optionally be used in combination with pneumococcal saccharides. The antigens may be used in pneumococcal vaccines, but may also be used as components in vaccines for immunising against multiple pathogens.